Craig E Devoe

6PUBLICATIONS
41CO-AUTHORS
ChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMolecular targetsSatisfiability and optimisation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 23, 2026
Sirexatamab in Combination with Bevacizumab and Chemotherapy as Second-Line Therapy for Advanced Colorectal Adenocarcinoma: the Phase II DeFianCe Trial.

|Sep 10, 2025
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.

Jennifer J Knox, Grainne O'Kane, Daniel King

|Aug 12, 2025
Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results.

Zev A Wainberg, Colin D Weekes, Muhammad Furqan

|Jan 09, 2024
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial.

Shubham Pant, Zev A Wainberg, Colin D Weekes

|Jun 12, 2023
Diversifying Eligibility to Enhance Real-World Results.

Fatima Fayyaz, Richard D Carvajal, Craig E Devoe

|Aug 31, 2019
Excellent Response to Nivolumab and Ipilimumab in Metastatic Gastroesophageal Junction Squamous Carcinoma.

Narayanan Sadagopan, Craig Devoe

Pageof 1

Frequent Collaborators

3 joint publications

Eileen M O'Reilly

2 joint publications

Christopher M Haqq

2 joint publications

Pashtoon M Kasi

2 joint publications

Shubham Pant